AAAAAA

   
Results: 1-8 |
Results: 8

Authors: MALMSTROM K MELTZER E PRENNER B LU S WEINSTEIN S WOLFE J WEI LX REISS TF
Citation: K. Malmstrom et al., EFFECTS OF MONTELUKAST (A LEUKOTRIENE RECEPTOR ANTAGONIST), LORATADINE, MONTELUKAST PLUS LORATADINE AND PLACEBO IN SEASONAL ALLERGIC RHINITIS AND CONJUNCTIVITIS, Journal of allergy and clinical immunology, 101(1), 1998, pp. 406-406

Authors: KOJIMA A UEDA M NARUKO T KOMATSU R WEI LX MATSUIYUASA I BECKER AE
Citation: A. Kojima et al., ENHANCED EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTORS (FLT-1 AND KDR FLK-1) MAY INDUCE A PLAQUE DESTABILIZATION IN HUMAN CORONARY ATHEROSCLEROTIC LESIONS/, Circulation, 98(17), 1998, pp. 887-887

Authors: NARUKO T UEDA M HAZE K KOMATSU R WEI LX KOJIMA A TAKIMOTO M OKADA T MASATSUGU K ITOH H
Citation: T. Naruko et al., INCREASED EXPRESSION OF ENDOTHELIN RECEPTORS IS ASSOCIATED WITH THE PROGRESSION OF ATHEROSCLEROSIS IN HUMAN CORONARY-ARTERIES, Circulation, 98(17), 1998, pp. 3850-3850

Authors: WEI LX TEICHBERG S MANN K SCHUSTER MW
Citation: Lx. Wei et al., CRL-1605 - A MORE POTENT DRUG IN A NOVEL CLASS OF SUBSTANCES USED TO REVERSE MULTIDRUG-RESISTANCE GENE (MDR1) EXPRESSION IN LEUKEMIA, Blood, 88(10), 1996, pp. 1440-1440

Authors: SHUSTER MW WEI LX SCHULMAN P KOLITZ J BUCHBINDER A ALLEN S LICHTMAN SM GELLER RB DEVINE SM HEFFNER LT MANN K
Citation: Mw. Shuster et al., CRL-1336 - FIRST OF A NOVEL CLASS OF DRUGS USED TO REVERSE MULTIDRUG-RESISTANCE (MDR1) GENE-EXPRESSION IN LEUKEMIA, Blood, 86(10), 1995, pp. 2069-2069

Authors: WEI LX TING TCT
Citation: Lx. Wei et Tct. Ting, EXPLICIT EXPRESSIONS OF THE BARNETT-LOTHE TENSORS FOR ANISOTROPIC MATERIALS, Journal of elasticity, 36(1), 1994, pp. 67-83

Authors: WEI LX WANG JZ
Citation: Lx. Wei et Jz. Wang, ESTIMATE OF CANCER RISK FOR A LARGE POPULATION CONTINUOUSLY EXPOSED TO HIGHER BACKGROUND-RADIATION IN YANGJIANG, CHINA, Chinese medical journal, 107(7), 1994, pp. 541-544

Authors: KASAYUKI N UEDA M WEI LX TERAGAKI M TAKEUCHI K TAKEDA T BECKER AE
Citation: N. Kasayuki et al., TENASCIN MAY SERVE AS MARKER FOR THE HEALING-PROCESS IN HUMAN CORONARY-ARTERIES AFTER PTCA, Circulation, 88(4), 1993, pp. 656-656
Risultati: 1-8 |